Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Coley acquires 3M's therapeutic Toll-like receptor R&D programs

June 15, 2007

NRC-IRAP contribution to support development of WBI-2100

June 15, 2007

Enrollment open in U.K. study of Reolysin with gemcitabine in advanced cancers

June 15, 2007

New phase I study for terameprocol in solid tumors

June 15, 2007

Snapshots of preclinical studies in hematology

June 15, 2007

Snapshots on cancer immunotherapy

June 15, 2007

Novel therapies targeting the prolactin receptor block tumor recurrence in breast cancer models

June 15, 2007

Priority review for oral Hycamtin in SCLC

June 14, 2007

Update on Abbott's chemotherapeutic program

June 14, 2007

Snapshots of clinical studies in hematology

June 14, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026